PRESS RELEASES

PRESS RELEASES

Date Title and Summary Additional Formats
Toggle Summary ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 23, 2023
ERYTECH Announces the Availability of the Documents for its Annual General Meeting to be held on June 2 3 , 20 2 3 Cambridge, MA (U.S.) and Lyon (France), May 24 , 202 3 – ERYTECH Pharma ( Nasdaq & Euronext: ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by
View HTML
Toggle Summary ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes
PRESS RELEASE ERYTECH announces the availability of the exemption document relating to the proposed combination with Pherecydes Lyon (France), May 23, 2023 - ERYTECH Pharma ( Nasdaq & Euronext : ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _May 15, 2023
                 Monthly information related to total number of voting rights and shares composing the share capital _ May 15, 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C - ISIN
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _April 30, 2023
                 Monthly information related to total number of voting rights and shares composing the share capital _ April 3 0 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH Provides Business and Financial Update for the First Quarter of 2023
ERYTECH Provides Business and Financial Update for the First Quarter of 2023          Combination with Pherecydes , i ntending to c reate a g lobal l eader in e xtended p hage t herapies to t arget antimicrobial resistant p athogenic b acteria to be submitted to shareholders' vote in June 2023 Cash
View HTML
Toggle Summary ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
ERYTECH Announces Approval to Transfer its Listing to the N asdaq Capital Market Cambridge, MA (U.S.) and Lyon (France), April 1 7 , 20 2 3 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances
View HTML
Toggle Summary  Monthly information related to total number of voting rights and shares composing the share capital _March 31, 2023
                 Monthly information related to total number of voting rights and shares composing the share capital _ March 31 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 20 2 2          Combination with Pherecydes a nnounced , i ntending to c reate a g lobal l eader in e xtended p hage t herapies t argeting antimicrobial resistant p athogenic b acteria Deep restructuring
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _January 31, 2023
               Monthly information related to total number of voting rights and shares composing the share capital _ January 3 1 , 202 3 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Toggle Summary Monthly information related to total number of voting rights and shares composing the share capital _December 31, 2022
                Monthly information related to total number of voting rights and shares composing the share capital _ December 3 1 , 202 2 . Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France Listing markets: Euronext Paris from Euronext (Market segment C -
View HTML
Top